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diagnosis of peroxisomal b-oxidation defects. J Clin Invest countries. As a major result, the 15257 mutation was
97:681–688 found in 6 (4%) of 159 families, and in every one of
Ravnik-Glavac M, Glavac D, Dean M (1994) Sensitivity of these instances it was associated with one of the estab-
single-stranded conformation polymorphism and hetero- lished primary LHON mutations, at np 11778 (in 4
duplex method for mutation detection in the cystic ﬁbrosis [5%] of 78 families), at np 3460 (in 1 [7%] of 14 fami-
gene. Hum Mol Genet 3:801–807
lies), and at np 14484 (in 1 [4%] of 23 families). BecauseSanger F, Nicklen S, Coulson RA (1977) DNA sequencing
the 15257 mutation did not occur in isolation of anwith chain terminating inhibitors. Proc Natl Acad Sci USA
established primary LHON mutation, Mackey et al.74:5463–5467
questioned whether there is a primary pathogenic roleShani N, Watkins PA, Valle D (1995) PXA1, a possible Sac-
for this mutation in the cytochrome b gene. However,charomyces cerevisiae ortholog of the human adrenoleuko-
dystrophy gene. Proc Natl Acad Sci USA 92:6012–6016 they also discussed possible doubts about this conclu-
Shefﬁeld VC, Beck JS, Kwitek AE, Sandstrom DW, Stone EM sion. As one of the points, they cited a report by our
(1993) The sensitivity of single-strand conformation poly- group (Obermaier-Kusser et al. 1994) on a German
morphism analysis for the detection of single base substitu- LHON family that carries the 15257 mutation but lacks
tions. Genomics 16:325–332 any of the three established primary mutations. We
Shimozawa N, Suzuki Y, Orii T, Moser A, Moser HW, Wan- would like to comment on this point. In the cited paper,
ders RJA (1993) Standardization of complementation
we described 17 families and sporadic cases in whichgrouping of peroxisome-deﬁcient disorders and the second
the mutation pattern included at least one primary orpatient with peroxisomal assembly factor-1 (PAF-1) defect.
intermediate mutation. The 15257 mutation was foundAm J Hum Genet 52:843–844
in three index patients; in two cases in association withShimozawa N, Suzuki Y, Tomatsu S, Tsukamoto T, Osumi
the 11778 or 14484 mutation and in one case withoutT, Fujiki Y, Kamijo K, et al (1996) Correction by gene
expression of biochemical abnormalities in ﬁbroblasts from any of the three primary mutations. Maternal inheri-
Zellweger patients. Pediatr Res 39:812–815 tance and male predominance in combination with the
Tan X, Titorenko VI, van der Klei IJ, Sulter GJ, Haima P, clinical features conﬁrm the classiﬁcation of LHON in
Waterham HR, Evers M, et al (1995) Characterization of this latter family. Of the eight families tested in that
peroxisome-deﬁcient mutants of Hansenula polymorpha. paper, the singleton 15257 family showed the highest
Curr Genet 28:248–257 penetrance (56%, all males). Meanwhile, we identiﬁed
Yajima S, Suzuki Y, Shimozawa N, Yamaguchi S, Orii T,
38 further LHON index cases. Our total LHON collec-Fujiki Y, Osumi T, et al (1992) Complementation study of
tive (n Å 55) now consists of 24 carriers of 11778, 5peroxisome-deﬁcient disorders by immunoﬂuorescence
carriers of 3460, and 21 carriers of 14484; the 15257staining and characterization of fused cells. Hum Genet 88:
mutation is found three times associated with np 11778,491–499
six times associated with np 14484, and ﬁve times with-
out any of the established primary mutations. The per-Address for correspondence and reprints: Dr. Barbara Paton, Department of
Chemical Pathology, Women’s and Children’s Hospital, 72 King William Road, centage of LHON patients carrying the 15257 mutation
North Adelaide SA 5006, Australia. E-mail: patonb@wch.sa.gov.au (25%) by far exceeds the ﬁnding by Mackey et al.*Present afﬁliation: Molecular Pathology Unit, Institute of Medical and Veter-
(1996). In the ﬁve cases without primary mutation, theinary Science, Adelaide.
**Present afﬁliation: School of Life Sciences, Queensland University of Tech- 15257 mutation behaves like a primary LHON muta-
nology, Brisbane. tion; however, we cannot exclude the possibility that 1997 by The American Society of Human Genetics. All rights reserved.
another, still-unknown primary mutation is present.0002-9297/97/6006-0033$02.00
Two other groups also reported singleton 15257 LHON
cases (Howell et al. 1993; Brown et al. 1995), and, in
these studies, other pathogenic mtDNA mutations could
be excluded by screening most of the mtDNA coding
Am. J. Hum. Genet. 60:1539–1542, 1997 regions.
The pathogenicity of the 15257 mutation is also dis-
cussed with respect to its haplogroup speciﬁcity. ThisDisease Relevance of the So-Called Secondary Leber
mutation is nearly always associated with the mutationsHereditary Optic Neuropathy Mutations
at nps 4216 and 13708 (Johns and Berman 1991; Brown
To the Editor: et al. 1992). Mackey et al. (1996, p. 484) concluded
that ‘‘the increased frequency of the 15257 mutationIn the August issue of the Journal, Mackey et al. (1996)
addressed the open question of the pathogenic role of among LHON patients can be explained solely in terms
of population history and genetics, rather than as a re-the mtDNA mutation at nucleotide position (np) 15257
in Leber hereditary optic neuropathy (LHON). This was ﬂection of its pathogenic role.’’ In order to look for an
association of certain haplogroups with distinct neuro-done by investigating a total of 159 LHON families
from Australia/New Zealand and from several European degenerative disorders, we currently are investigating
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the entire mitochondrial genome of our total LHON primary LHON mutations at np 3460, 11778, or 14484,
which are also found in association with other haplo-collective (n Å 55) and of eight DIDMOAD (diabetes
insipidus, diabetes mellitus, optic atrophy, and deafness) groups, the 15257 mutation is associated nearly exclu-
sively with haplogroup A, thus creating a highly patho-patients by use of SSCP analysis and direct sequencing
of PCR-ampliﬁed fragments. The sequence data sets (in- genic subbranch of this haplogroup. However, two
15257-positive cases were found in association with npcluding variants of all ND, tRNA, and cyt b genes) are
analyzed with regard to common mutation clusters 4917. One of these patients did not harbor any of the
common primary LHON mutations, a ﬁnding further(haplogroups) in the respective disease groups. The
haplogroup frequencies in disease groups are compared arguing in favor of a pathogenic role of the 15257 muta-
tion, even in the absence of the 4216/13708 haplo-with those in a group of healthy German blood donors
(n Å 67). Of the 67 control subjects, none carried the group background.
From a clinical point of view, Mackey et al. (1996,15257 mutation. Of the 14 LHON cases who were
15257 positive, 12 (86%) were found in association p. 482) discussed the possibility that LHON is not a
single entity but can, in simplest terms, be subdividedwith the mutations at nps 4216 and 13708. These muta-
tions are commonly in association with further ND gene into two broad groups. ‘‘In the ﬁrst group the optic
neuropathy is the most prominent, if not the exclusive,polymorphisms at nps 10398, 11251, and 12612 (ﬁg.
1), forming a distinct haplogroup (termed ‘‘A’’ in ﬁg. 1) clinical deﬁcit, although there may be extra-ophthalmo-
logic abnormalities, including peripheral neuropathy,that, because of a DdeI restriction-site gain at np 10394
and a BstNI restriction site loss at np 13704, presumably heart conduction defects, and a multiple sclerosis–like
condition, in a small proportion of family members. Inis consistent with the European haplogroup J (Torroni
et al. 1994). It represents 6% (4 of 67 controls) of our contrast, there are other families that present severe neu-
rological abnormalities, which also are maternally inher-healthy German control group, a frequency slightly
lower than those described for other Caucasian popula- ited and which are more prominent than the optic neu-
ropathy.’’ Mackey et al. stated that these latter ‘‘LHON-tions (Torroni et al. 1994, 1996b). In contrast to the
plus’’ families involve pathogenic mutations different
from those that produce the more ophthalmologically
limited disorder and that these mutations seem to create
speciﬁc LHON-plus disorders. In this respect a recent
publication by Ro¨del et al. (1996) is of interest. These
authors investigated the association of the 13708 and
15257 mutations with neurodegenerative diseases dis-
tinct from LHON and without primary LHON muta-
tions. Two hundred unselected neurology patients and
100 subjects suffering from multiple sclerosis (MS) were
screened for both mutations. Seven neurology patients
(3.5%) and two patients with MS (2%) were found to
carry both the 13708 mutation and the 15257 mutation,
indicating that these patients also belong, in all probabil-
ity, to haplogroup A. Thus, the 15257 mutation seems
to be frequently associated with neurological symptoms,
conﬁrming the pathogenic role of this side branch of
haplogroup A, but cannot be regarded as exclusively an
LHON mutation.
The same holds true for the so-called secondary
LHON mutations at nps 4216, 4917, and 13708,
Figure 1 mtDNA haplotypes of 4216-positive LHON and which deﬁne distinct phylogenetic clusters also found
DIDMOAD patients. Sequence data included in this cladogram in the healthy Caucasian population. As shown in
come from the mtDNA screening of 17 LHON (L) patients, 8
ﬁgure 1, subjects carrying the 4216/11251 combina-DIDMOAD (D) patients, and 67 controls (C); mtDNA haplotype
tion split into haplogroups A and B; the latter is de-analysis of the remaining LHON cases (n Å 38) is currently under
investigation. 4216–wild-type patients (i.e., seven LHON patients ﬁned by variants at nps 4216, 11251, 4917, 10463,
and two DIDMOAD patients) are not included in this ﬁgure. Num- 13368, 14905, 15607, 15928, and 14233 and presum-
ber of LHON or DIDMOAD patients belonging to the distinct ably is consistent with the European-speciﬁc haplo-
branches is indicated in parentheses. All subbranches associated
group T (Torroni et al. 1996b). The established pri-with DIDMOAD patients were deﬁned by further coding-region
mary LHON mutations at nps 11778, 3460, andvariants not depicted here. The different levels of mutation clusters
are not correlated with speciﬁc genetic distances. 14484 are not randomly distributed over the various
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haplogroups but accumulate in haplogroup A (ﬁg. 1). for genetic heterogeneity (Collier et al. 1996). Never-
theless, we observe that six (75%) of eight DID-Concerning our total LHON collective (n Å 55), 14
(66%) of 21 cases who were 14484 positive, 11 (46%) MOAD patients carry the 4216/11251 variants (ﬁg.
1); one 4216 carrier belongs to a separated side branchof 24 cases who were 11778 positive, and 2 (40%) of
5 cases who were 3460 positive were found in associa- of haplogroup A, and ﬁve 4216 carriers (or 63% of
all investigated DIDMOAD patients) belong to haplo-tion with a 4216/13708 background. Explanations
for this observation are under discussion (Brown et group B (Hofmann et al. 1997); in contrast, the fre-
quency in our German control group is only 9% (6 ofal. 1995; Howell et al. 1995; Torroni et al. 1996a).
Howell et al. (1995) proposed two possible situations 67 controls). Thus, the possibility might exist that
severe mutations of both nuclear or mitochondrial ori-to explain the high frequency of LHON in haplogroup
A. One is that the mtDNA variants deﬁning haplo- gin are indeed randomly associated with all mitochon-
drial haplogroups but will reach disease quality—thatgroup A as well as the respective primary LHON mu-
tations had arisen multiple times during human evolu- is, manifestation or penetrance—mainly when associ-
ated with a certain mitochondrial haplogroup. If so,tion. Such a situation is not supported by the data
available from the literature (Howell et al. 1995). The such a condition could have important implications
for polygenic disorders such as diabetes, hypertension,other extreme is the ‘‘single-origin model’’ of the sec-
ondary LHON mutations. If it is assumed that the etc.
We propose that, in contrast to the primary LHON13708 mutation (vicariously representing haplogroup
A) arose once within the population and, for example, mutations, which are obviously LHON speciﬁc, the
so-called secondary LHON mutations are not patho-that ‘‘the 11778 mutation arose late in the history of
a non-13708 line of descent but arose early in that of gnomonic for LHON but seem to create a susceptibil-
ity basis for certain neurodegenerative disorders in athe 13708 line, then the most likely sampling outcome
will be a high proportion of 11778/13708 LHON way that, so far, is unknown. The term secondary
LHON mutations, therefore, should be dropped, atpedigrees’’ (Howell et al. 1995, p. 296). If this as-
sumption is true, then it must be considered valid also least with respect to nps 4216, 4917, and 13708.
for the other two primary LHON mutations, since
not only the 11778 mutation but also the two other
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Johns DR, Berman J (1991) Alternative, simultaneous complex linked disease, which previously had been mapped to
I mitochondrial DNA mutations in Leber’s hereditary optic
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mutation patterns in European pedigrees and sporadic cases characterized to date (Laporte et al. 1996). We report
with Leber hereditary optic neuropathy. Am J Hum Genet here that a missense mutation indeed was found in the
55:1063–1066
proband but was not present in his mother and inPolymeropoulos MH, Swift RG, Swift M (1994) Linkage of
three other females thought to be carriers (see ﬁg. 1),the gene for Wolfram syndrome to markers on the short
on the basis of detection of some small ﬁbers witharm of chromosome 4. Nat Genet 8:95–97
centrally located nuclei in the muscle biopsies of theseRo¨del G, Laubhan R, Scheuerle A, Skowronek P, Haferkamp
individuals.O (1996) Association of the LHON 13708 and 15257 mito-
chondrial DNA mutations with neurodegenerative diseases In our previous analysis, we reported that the unaf-
distinct from LHON. Eur J Med Res 1:491–494 fected boy (III.6) had inherited the same maternal al-
Torroni A, Carelli V, Petrozzi M, Terracina M, Barboni P, leles at the FRAXAC2 and DXS305 loci ﬂanking
Malpassi P, Wallace DC, et al (1996a) Detection of the MTM1 as were seen in the proband (III.4) and his
mtDNA 14484 mutation on an African-speciﬁc haplotype: putative carrier sister (III.3). However, a double re-
implications about its role in causing Leber hereditary optic combination within FRAXAC2-DXS305, an interval
neuropathy. Am J Hum Genet 59:248–252
of Ç10 cM, could not be formally excluded (SamsonTorroni A, Huoponen K, Francalacci P, Petrozzi M, Morelli
et al. 1995). The study of three microsatellite markersL, Scozzari R, Obinu D, et al (1996b) Classiﬁcation of Euro-
much closer to the MTM1 gene (Hu et al. 1996a;pean mtDNAs from an analysis of three European popula-
Laporte et al. 1996) now conﬁrms that the same hap-tions. Genetics 144:1835–1850
lotype indeed was transmitted to all four children ofTorroni A, Lott MT, Cabell MF, Chen Y-S, Lavergne L, Wal-
lace DC (1994) mtDNA and the origin of Caucasians: identi- II.4 and also is present in the putative carriers (II.1
ﬁcation of ancient Caucasian-speciﬁc haplogroups, one of and II.2).
which is prone to a recurrent somatic duplication in the D- SSCP analysis was performed on ﬁve exons covering
loop region. Am J Hum Genet 55:760–776 752 bp of coding sequence. For the exon encoding
amino acids 370–438 (exon c, according to Laporte
et al. 1996), we found four different band patterns
Address for correspondence and reprints: Dr. Sabine Hofmann, Institute fu¨r (ﬁg. 2). Sequencing of variant bands revealed the pres-Klinische Chemie und Diabetesforschung, Krankenhaus Mu¨nchen-Schwabing,
ence of two base-pair changes in the 5 end of theKo¨lner Platz 1, 80804 Mu¨nchen, Germany. E-mail: diabetes@lrz.uni-
muenchen.de following intron, deﬁning three alleles (ﬁg. 3). Alleles
 1997 by The American Society of Human Genetics. All rights reserved. 1 and 2 differ at the consensus donor site and are0002-9297/97/6006-0034$02.00
common variants in the normal population (J. La-
porte, unpublished data). Allele 3, with an additional
intronic change, is much rarer. It is present in the
grandmother and also in III.2, in the latter of whom
Am. J. Hum. Genet. 60:1542–1544, 1997 it must derive from the married-in father. It is thus
also a polymorphism. The fourth variant was detected
only in the proband (and, notably, was absent in hisA Mutation in the MTM1 Gene Invalidates a Previous
mother), when slow electrophoretic migration wasSuggestion of Nonallelic Heterogeneity in X-Linked
used, conditions in which the 1/2 polymorphism isMyotubular Myopathy
barely detectable (ﬁg. 2a and b). On direct sequencing,
To the Editor: we found an exonic single-base-pair change, A1244G.
This results in a change of tyrosine 415 to a cysteine,We reported previously in the Journal (Samson et al.
1995, p. 120) the study of a family with a single case in the predicted protein, called ‘‘myotubularin.’’ This
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